Meeting
2014 ASCO Annual Meeting
Long-term quality of life among localized prostate cancer survivors: Qalipro population-based study.
Authors
Anne-Valérie Guizard
Centre François Baclesse, Caen, France
Anne-Valérie Guizard , Clarisse Kerleau , Pascale Grosclaude , Mariette Mercier , Natacha Heutte , Florence Joly
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Survivorship
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 9594)
DOI
10.1200/jco.2014.32.15_suppl.9594
Abstract #
9594
Poster Bd #
244
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Self-reported functional assessment by patients receiving different prostate cancer strategies: Five-year results from the VICAN large prospective cohort.
First Author: G Raldine Pignot
Poster
2024 ASCO Genitourinary Cancers Symposium
Relugolix versus leuprolide in combination with radiotherapy for localized prostate cancer (REVELUTION trial): An initial analysis of patient treatment preferences and quality of life.
First Author: Sagar A. Patel
Poster
2023 ASCO Genitourinary Cancers Symposium
Urinary proteome as a prognostic factor in the deterioration of the quality of life of patients with localized prostate cancer during radiotherapy: Radiotoxicity Bladder Biomarkers (RABBIO) prospective trial.
First Author: Carole Helissey
Poster
2023 ASCO Genitourinary Cancers Symposium
Sexual function after primary external beam radiation therapy (EBRT) for prostate cancer in a large cohort of men with long-term follow-up.
First Author: Domenique Escobar